1.
SPECIFIC AIMS The long-term goal of this research is to understand the function and regulation of the mammalian INK4 family of CDK inhibitors. All four INK4 proteins specifically bind to and inhibit the kinase activity of cyclin D-dependent CDK4 and CDK6, thereby retaining the growth suppressive activity of the retinoblastoma family proteins and preventing G1-to-S transition. Through concerted efforts by many laboratories over the past six years, the biochemical mechanisms underlying the inhibition of CDK4/6 by INK 4 inhibitors are now relatively well understood. However, both in vivo functions of INK4 genes and signals regulating INK4 gene expression remain poorly defined.
The aims of this proposal are directed toward both issues, with focus on two members of the family: p18/INK4c and p19/INK4d.
AIM 1. THE FUNCTION OF P18/INK4C IN TUMOR SUPPRESSION 1. Determine the tumor susceptibility of p18-deficient mice. 2. Determine whether p18 functional interact with p53 3. Examine the status of the p18 functional interact with p53. 4. Identifying gene(s) collaborating with p189 loss in lymphomagenesis by pro-virus insertional mutagenesis.
AIM II. REGULATION OF P18/INK4C AND P27/KIP1 BY MEN GENES 1. Determine whether p18 and p27 are regulated by menin tumor suppressor 2. Determine whether p18 and p27 are regulated by RET proto-oncogene.
AIM III. FUNCTION OF P18/INK4C IN CELL DIFFERENTIATION 1. Determine the function of p18 and p27 in maintaining terminal arrest of myotubes 2. Determine the function of p18 in inducing terminal arrest of adipocytes AIM IV. GENETIC FUNCTION OF P19/INK4D 1. Determine the function of p19 in controlling cellular proliferation 2. Determine the basis for the phenotypic difference between two INK4d mutant mice 3. Determine whether E2F1 and p53 are the downstream targets of p19 loss-induced apoptosis. 4. Determine the cell cycle kinetics of p19- and p18-deficient embryo fibroblasts

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA068377-06
Application #
6287284
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Spalholz, Barbara A
Project Start
1995-07-17
Project End
2006-01-31
Budget Start
2001-02-21
Budget End
2002-01-31
Support Year
6
Fiscal Year
2001
Total Cost
$299,786
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Biochemistry
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Ye, Dan; Guan, Kun-Liang; Xiong, Yue (2018) Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates. Trends Cancer 4:151-165
Li, Z; Xiong, Y (2017) Cytoplasmic E3 ubiquitin ligase CUL9 controls cell proliferation, senescence, apoptosis and genome integrity through p53. Oncogene 36:5212-5218
Han, X-R; Zha, Z; Yuan, H-X et al. (2016) KDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulation. Oncogene 35:4179-90
Vulto-van Silfhout, Anneke T; Nakagawa, Tadashi; Bahi-Buisson, Nadia et al. (2015) Variants in CUL4B are associated with cerebral malformations. Hum Mutat 36:106-17
Li, Zhijun; Pei, Xin-Hai; Yan, Jun et al. (2014) CUL9 mediates the functions of the 3M complex and ubiquitylates survivin to maintain genome integrity. Mol Cell 54:805-19
Yan, Jun; Yan, Feng; Li, Zhijun et al. (2014) The 3M complex maintains microtubule and genome integrity. Mol Cell 54:791-804
Gama, Vivian; Swahari, Vijay; Schafer, Johanna et al. (2014) The E3 ligase PARC mediates the degradation of cytosolic cytochrome c to promote survival in neurons and cancer cells. Sci Signal 7:ra67
Xu, Yanping; Li, Fulong; Lv, Lei et al. (2014) Oxidative stress activates SIRT2 to deacetylate and stimulate phosphoglycerate mutase. Cancer Res 74:3630-42
Lin, Ruiting; Tao, Ren; Gao, Xue et al. (2013) Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth. Mol Cell 51:506-518
Zhou, Xin; Li, Ting-Ting; Feng, Xu et al. (2012) Targeted polyubiquitylation of RASSF1C by the Mule and SCF?-TrCP ligases in response to DNA damage. Biochem J 441:227-36

Showing the most recent 10 out of 40 publications